Core Points - The article outlines the fundraising management system of Shanghai MicroPort CardioMed Technology (Group) Co., Ltd, aiming to enhance the safety and efficiency of fund usage while protecting investors' rights [2][21] - The system is established in accordance with various laws and regulations, including the Company Law and Securities Law of the People's Republic of China [2] Fundraising Management - The company defines fundraising as funds raised through the issuance of securities to unspecified or specific objects, excluding funds raised for equity incentive plans [2] - Upon receipt of funds, the company must promptly conduct verification procedures and ensure that funds are stored in a designated account approved by the board of directors [4][6] - The board of directors is responsible for the management and usage of the raised funds, with oversight from the audit committee and sponsor institutions [2][3] Fund Storage - Funds must be stored in a special account dedicated to fundraising, and cannot be used for other purposes [4][6] - A tripartite supervision agreement must be signed with the sponsor institution and the commercial bank within one month of the funds being received [6] Fund Usage - The company must use the raised funds in accordance with the approved investment plans and must disclose any significant deviations from these plans [9][10] - If a project cannot be completed within the original timeframe, the company must disclose the reasons and the current status of the funds [10][11] - The company is prohibited from using the funds for financial investments or providing them to controlling shareholders for improper benefits [12][13] Changes in Fund Usage - Any changes in the use of raised funds must be approved by the board of directors and disclosed to shareholders [20][21] - The company must conduct feasibility analyses for new investment projects and ensure that they align with the main business operations [22][23] Oversight and Reporting - The company is required to regularly disclose the status of fund usage and any changes in investment plans in its annual and semi-annual reports [16][20] - The sponsor institution or independent financial advisor must conduct ongoing supervision and report any irregularities to the Shanghai Stock Exchange [16][17]
心脉医疗: 心脉医疗:募集资金管理制度(2025年8月修订)